Stockreport

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Skye Bioscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SKYE

Skye Bioscience, Inc.  (SKYE) 
PDF NEW YORK, Nov. 30, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Skye Bioscience, Inc. (NASDAQ [Read more]